LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
VALN
Valneva SE
There isn't enough reported data to score VALN yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
VALN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Weak |
VALN's revenue, profitability, cash flow and balance sheet are all currently under pressure.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
VALN PE Valuation
VALN has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over VALN on the outlook, with more favorable earnings and revenue expectations.
VALN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect VALN's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the stronger earnings trend. Trailing diluted EPS is up 51% for LLY versus VALN down 1,613%.
VALN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$1.21 | -1613% |
| Q3 2025 | -$1.16 | -1155% |
| Q2 2025 | -$0.73 | -$0.43 |
| Q1 2025 | -$0.98 | -$0.83 |
| Q4 2024 | $0.08 | +$1.45 |
| Q3 2024 | $0.11 | +$1.65 |
| Q2 2024 | -$0.30 | -140% |
| Q1 2024 | -$0.15 | +$2.34 |
VALN has swung to a loss: it lost $1.21 per share over the past year, after a profit the year before.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the stronger quarterly revenue trend. Revenue is up 39% for LLY versus down 9.9% for VALN.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
VALN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $53M | -9.9% |
| Q3 2025 | $32.7M | -36% |
| Q2 2025 | $53.7M | +27% |
| Q1 2025 | $54.7M | +50% |
| Q4 2024 | $58.8M | +26% |
| Q3 2024 | $50.9M | +20% |
| Q2 2024 | $42.3M | -5.4% |
| Q1 2024 | $36.4M | -2.3% |
VALN's revenue fell from its 2021 peak and has held roughly level since: $53M last quarter, down 9.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -59% | -20 points |
| Q3 2025 | -126% | -99 points |
| Q2 2025 | -22% | +34 points |
| Q1 2025 | -12% | -220 points |
| Q4 2024 | -39% | +20 points |
| Q3 2024 | -27% | +31 points |
| Q2 2024 | -57% | -11 points |
| Q1 2024 | 208% | +258 points |
VALN's operating margin was −59% last quarter, down 20 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with VALN at up 31%.
VALN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$28.4M | -552% |
| Q3 2025 | -$20.1M | +$9.2M |
| Q2 2025 | -$4.5M | +$37.1M |
| Q1 2025 | -$10.7M | +$25.9M |
| Q4 2024 | $6.3M | +$86M |
| Q3 2024 | -$29.3M | +$51.4M |
| Q2 2024 | -$41.6M | +$7.8M |
| Q1 2024 | -$36.6M | -$5.4M |
VALN has burned cash in most quarters: −$64M over the past year, against −$101M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over VALN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
VALN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +96% | +82.3M shares |
| 1 year | +15% | +22.5M shares |
| 3 years | +46% | +52.7M shares |
| 5 years | +266% | +122M shares |
| Available history | +307% | +127M shares |
VALN has 168M diluted shares, up 15% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q3 2023 | $49,991 |
| Q2 2023 | $101,092 |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
VALN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2020 | 5.5x | High |
| Q4 2019 | 2.3x | Moderate |
| Q3 2019 | 1.3x | Healthy |
| Q2 2019 | 0.4x | Very low |
| Q1 2019 | 0.5x | Very low |
| Q4 2018 | -1.4x | Net Cash |
| Q3 2018 | 18.4x | High |
| Q2 2018 | 12.1x | High |
VALN's net debt is about 5.5 years of its operating earnings (EBITDA), up from less than a year a year ago.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
VALN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.9 | Neutral |
| Stochastic | 23.6 | Neutral |
VALN's weekly RSI is 46 (neutral) and its Stochastic is 24 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
VALN PE vs Healthcare Sector
VALN has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over VALN on trend strength, trading above more of its moving averages.
VALN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.66 | 1.8% above |
| 20 week MA | $5.81 | 0.9% below |
| 50 week MA | $7.03 | 18% below |
| 100 week MA | $7.19 | 20% below |
| 200 week MA | $8.51 | 32% below |
VALN has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 32% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over VALN on returns for 2026, with the stronger performance.
VALN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $29.5 | $57.3 | +94% |
| 2022 | $57.3 | $14.2 | -75% |
| 2023 | $14.2 | $10.4 | -27% |
| 2024 | $10.4 | $4.33 | -58% |
| 2025 | $4.33 | $8.41 | +94% |
| 2026 YTD | $8.41 | $5.76 | -32% |
VALN has finished lower in three of the last five years. It's down 32% so far in 2026.